Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Delayed: 1.92 +0.03 (1.59%)
Previous Close $1.89    52 Week High $19.62 
Open $1.89    52 Week Low $7.65 
Day High $2.03    P/E N/A 
Day Low $1.88    EPS $-0.22 
Volume 2,994,445       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 12.87 +0.31 (2.47%)
Previous Close $12.56    52 Week High $5.58 
Open $12.61    52 Week Low $3.60 
Day High $12.88    P/E N/A 
Day Low $12.53    EPS $0.00 
Volume 8,251,235       

SANOFI (NASDAQ: SNY) Delayed: 44.25 +0.14 (0.32%)
Previous Close $44.11    52 Week High $44.76 
Open $44.11    52 Week Low $36.81 
Day High $44.51    P/E N/A 
Day Low $44.02    EPS $0.00 
Volume 1,633,184